NZ262794A - Treating enteroviral infections with a 4-(4-(phenoxymethyl)phenylmethoxy)benzene derivative - Google Patents

Treating enteroviral infections with a 4-(4-(phenoxymethyl)phenylmethoxy)benzene derivative

Info

Publication number
NZ262794A
NZ262794A NZ262794A NZ26279494A NZ262794A NZ 262794 A NZ262794 A NZ 262794A NZ 262794 A NZ262794 A NZ 262794A NZ 26279494 A NZ26279494 A NZ 26279494A NZ 262794 A NZ262794 A NZ 262794A
Authority
NZ
New Zealand
Prior art keywords
formula
enterovirai
compound
enteroviruses
enterovirus
Prior art date
Application number
NZ262794A
Other languages
English (en)
Inventor
Edward J Rozhon
John F O'connell
Peter Buontempo
Stuart Cox
Jason L Demartino
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ262794A publication Critical patent/NZ262794A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ262794A 1993-02-26 1994-02-23 Treating enteroviral infections with a 4-(4-(phenoxymethyl)phenylmethoxy)benzene derivative NZ262794A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2352793A 1993-02-26 1993-02-26

Publications (1)

Publication Number Publication Date
NZ262794A true NZ262794A (en) 1997-03-24

Family

ID=21815649

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ262794A NZ262794A (en) 1993-02-26 1994-02-23 Treating enteroviral infections with a 4-(4-(phenoxymethyl)phenylmethoxy)benzene derivative

Country Status (12)

Country Link
EP (1) EP0686032A1 (cs)
JP (1) JPH08507062A (cs)
AU (1) AU691490B2 (cs)
CA (1) CA2156916A1 (cs)
FI (1) FI953980L (cs)
HU (1) HUT72490A (cs)
IL (1) IL108749A0 (cs)
MX (1) MXPA94001379A (cs)
NZ (1) NZ262794A (cs)
TW (1) TW284686B (cs)
WO (1) WO1994018960A1 (cs)
ZA (1) ZA941244B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020070390A1 (en) 2018-10-03 2020-04-09 Jyväskylän Yliopisto Vemurafenib and salts thereof for use in the treatment of enteroviral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8412799U1 (de) * 1984-04-26 1984-10-31 William Prym-Werke Kg, 5190 Stolberg SB-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung fuer Fadenlegewerkzeuge wie Stricknadeln
CZ279793A3 (en) * 1991-06-19 1994-05-18 Schering Corp Orally active antiviral compounds

Also Published As

Publication number Publication date
FI953980A7 (fi) 1995-08-24
CA2156916A1 (en) 1994-09-01
MXPA94001379A (es) 2011-09-26
AU6267994A (en) 1994-09-14
HUT72490A (en) 1996-05-28
IL108749A0 (en) 1994-05-30
WO1994018960A1 (en) 1994-09-01
TW284686B (cs) 1996-09-01
AU691490B2 (en) 1998-05-21
EP0686032A1 (en) 1995-12-13
ZA941244B (en) 1994-08-23
FI953980A0 (fi) 1995-08-24
JPH08507062A (ja) 1996-07-30
FI953980L (fi) 1995-08-24
HU9502494D0 (en) 1995-10-30

Similar Documents

Publication Publication Date Title
RU2700415C1 (ru) Ингибиторы репликации вирусов гриппа
CN112409379B (zh) 氘代的二氢二苯并硫杂卓化合物以及包含该化合物的药物组合物
CA3166282A1 (en) Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia
KR20120044930A (ko) 고병원성 감염성 질환의 예방 및 치료제
TW201306839A (zh) 治療hcv感染之組合療法
CN110603041A (zh) 用于治疗流感病毒感染的组合治疗
AU691490B2 (en) Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans
JP2006515361A (ja) ヘルペスウイルス感染の症候を治療又は予防する方法
US20130245108A1 (en) Novel Antischistosomal Agent
US20220409583A1 (en) Treatment and Prevention of Dengue Disease
CA1147752A (en) Isoprenylamines
Fu et al. Comparison of the different medications for COVID-19 in kidney transplant recipients
CN102335171A (zh) 一类n-(2-噻唑)苯甲酰胺衍生物的应用
US4303658A (en) Antiviral pyrazolopyrazines
Togo et al. Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection
CN113546067B (zh) 具有抗病毒作用的蒽醌衍生物
CN118831089A (zh) 土贝母皂苷甲在制备调节性t细胞分化抑制剂中的应用
CN107320471A (zh) 一种治疗结核病的环丝氨酸药物组合物及其应用
NAIDU et al. CHAPTER FOUR CHARACTERISTICS, PROPERTIES AND ANALYTICAL PROFILE OF ANTIRETROVIRAL DRUG MOLNUPIRAVIR (SARS-COV-2): A MINI REVIEW
JPH03167125A (ja) 抗水痘―帯状疱疹ウイルス剤
WO2023040990A1 (zh) 治疗冠状病毒感染的新联用药物、药物组合物及其用途
Straube-West et al. Enteroviruses
CN113143920A (zh) Ponesimod化合物在制备抗EV71病毒药物中的应用
EA049504B1 (ru) Лечение и профилактика лихорадки денге
CN113082028A (zh) Alpelisib化合物在制备抗EV71病毒药物中的应用